Immunophenotyping of the PD-L1-positive cells in angioimmunoblastic T cell lymphoma and Hodgkin disease

OBJECTIVE: Programmed death-1 (PD-1) and its ligand PD-L1 are now used as predictive biomarkers to guide clinical decisions. Precise characterization of PD-L1-positive cells may contribute to our knowledge of which patients derive benefit from the PD-L1 blockade therapy. RESULTS: To address this iss...

Descripción completa

Detalles Bibliográficos
Autores principales: Tiemann, Markus, Samoilova, Vera, Atiakshin, Dmitri, Buchwalow, Igor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Note
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7060537/
https://www.ncbi.nlm.nih.gov/pubmed/32143684
http://dx.doi.org/10.1186/s13104-020-04975-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7060537/
https://www.ncbi.nlm.nih.gov/pubmed/32143684
http://dx.doi.org/10.1186/s13104-020-04975-w

Ejemplares similares